European study confirms that HIV treatment within three months of birth improves outcome for HIV-positive infants
Double-dose lopinavir/ritonavir provides insufficient lopinavir exposure in children on rifampicin-based TB treatment
ART use in mothers with low CD4 cell counts reduces breastfeeding transmission fivefold: Malawi
Kaletra superior to nevirapine-based ART for women already exposed to single-dose nevirapine
Nearly half of new infant HIV infections in Botswana may result from mothers infected during pregnancy or after delivery
HIV treatment during pregnancy does not increase risk of birth abnormalities – even when efavirenz included
New 75mg darunavir tablet approved by FDA for use by HIV-positive children
Childhood TB (part 3): treatment and prevention
Childhood TB (part 2): presentation and diagnosis
